Christopher Barys
Director/Board Member at UROLOGIX, INC.
Profile
Christopher R.
Barys is currently serving as an Independent Director at Urologix, Inc. since 2010, as a Director at CloSys Corp.
since 2014, as a Director & President-US Region at Radiaction Ltd.
since 2023, and as VP & General Manager-Interventional Lung Solutions at Covidien Unlimited Co. Mr. Barys previously held positions as President, Chief Executive Officer & Director at On Target Laboratories LLC from 2019 to 2023, Director-Global Market Development at Cordis Corp.
in 2005, Vice President & General Manager at I-Flow Corp., Principal at Johnson & Johnson and Boston Scientific Corp., Vice President-Sales & Marketing at Edwards Lifesciences Corp.
from 2005 to 2007, and General Manager at Kimberly-Clark Health Care, Inc. Mr. Barys also served as Chief Operating Officer at FlowCardia, Inc. in 2010 and as Chief Operating Officer at Sonablate Corp.
Mr. Barys completed his undergraduate degree at Northern Illinois University.
Christopher Barys active positions
| Companies | Position | Start |
|---|---|---|
| UROLOGIX, INC. | Director/Board Member | 2010-08-05 |
Covidien Unlimited Co.
 Covidien Unlimited Co. Medical SpecialtiesHealth Technology Covidien Unlimited Co. engages in the development, manufacture, and sale of healthcare products for use in clinical and home settings. It operates through Medical Devices and U.S. Medical Supplies segments. The Medical Devices segment involves in the distribution of surgical solutions, peripheral vascular and neurovascular therapies, patient monitoring products, and airway and ventilation products. The U.S. Medical Supplies segment includes marketing of nursing care, medical surgical, SharpSafety brand, and original equipment manufacturer (OEM) products. The company was founded in 1967 and is headquartered in Dublin, Ireland. | Corporate Officer/Principal | - |
CloSys Corp.
 CloSys Corp. Medical SpecialtiesHealth Technology CloSys Corp. designs, develops, and manufactures medical devices. It specializes in vascular closure devices that are used in interventional cardiology and peripheral vascular procedures to close the arterial access site. The company was founded on June 1, 1999 and is headquartered in St. Paul, MN. | Director/Board Member | 2014-12-08 |
Radiaction Ltd.
 Radiaction Ltd. Electronic Equipment/InstrumentsElectronic Technology Radiaction Ltd.engages in the development of an innovative radiation shielding system. Its technology offers full body protection, automatic operation, zero-impact on image quality, and lead-free and non-toxic materials. The company was founded by Amir Belson in 2014 and is headquartered in Tel Aviv, Israel. | Director/Board Member | 2023-08-28 |
Former positions of Christopher Barys
| Companies | Position | End |
|---|---|---|
On Target Laboratories LLC
 On Target Laboratories LLC BiotechnologyHealth Technology On Target Laboratories LLC develops precise and innovative small molecules whose goal is to target and illuminate cancer and other diseased tissue. The company is headquartered in Northbrook, IL. | Chief Executive Officer | 2023-06-30 |
I-Flow Corp.
 I-Flow Corp. Medical SpecialtiesHealth Technology I-Flow Corp. designs, develops and manufactures ambulatory drug delivery systems. Its products include portable infusion pumps, catheters and pain kits. The company was founded in 1985 and is headquartered in Lake Forest, CA. | Corporate Officer/Principal | 2014-01-31 |
FlowCardia, Inc.
 FlowCardia, Inc. Medical SpecialtiesHealth Technology FlowCardia, Inc. designs, develops and manufactures endovascular devices. It offers flowmate Injector to optimize the performance of crosser cto recanalization and crosser catheter, a minimally-invasive endovascular device. The firm also provides portfolio of catheter-based technologies to facilitate guidewire crossing of totally occluded coronary and peripheral arteries. The company was founded by Henry Nita and Erik T. Engelson in 2001 and is headquartered in Sunnyvale, CA. | Chief Operating Officer | 2010-05-31 |
| EDWARDS LIFESCIENCES CORPORATION | Sales & Marketing | 2007-10-31 |
Cordis Corp.
 Cordis Corp. Medical SpecialtiesHealth Technology Cordis Corp. develops and manufactures devices for interventional vascular medicine and electrophysiology. The firm's products include guidewires, balloons, forceps, catheters, and stents to treat a variety of circulatory system problems including coronary artery disease and cerebral aneurysms. The company was founded by William P. Murphy Jr. in 1959 and is headquartered in Milpitas, CA. | Corporate Officer/Principal | - |
Training of Christopher Barys
| Northern Illinois University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| BOSTON SCIENTIFIC CORPORATION | Health Technology |
| UROLOGIX, INC. | Health Technology |
| EDWARDS LIFESCIENCES CORPORATION | Health Technology |
| Private companies | 9 |
|---|---|
Cordis Corp.
Cordis Corp. Medical SpecialtiesHealth Technology Cordis Corp. develops and manufactures devices for interventional vascular medicine and electrophysiology. The firm's products include guidewires, balloons, forceps, catheters, and stents to treat a variety of circulatory system problems including coronary artery disease and cerebral aneurysms. The company was founded by William P. Murphy Jr. in 1959 and is headquartered in Milpitas, CA. | Health Technology |
I-Flow Corp.
I-Flow Corp. Medical SpecialtiesHealth Technology I-Flow Corp. designs, develops and manufactures ambulatory drug delivery systems. Its products include portable infusion pumps, catheters and pain kits. The company was founded in 1985 and is headquartered in Lake Forest, CA. | Health Technology |
CloSys Corp.
CloSys Corp. Medical SpecialtiesHealth Technology CloSys Corp. designs, develops, and manufactures medical devices. It specializes in vascular closure devices that are used in interventional cardiology and peripheral vascular procedures to close the arterial access site. The company was founded on June 1, 1999 and is headquartered in St. Paul, MN. | Health Technology |
Kimberly-Clark Health Care, Inc.
 Kimberly-Clark Health Care, Inc. Medical SpecialtiesHealth Technology Kimberly-Clark Health Care, Inc. manufactures and markets surgical equipment. It offers surgical drapes, gowns, sterilization wrap and pouches, personal protective apparel and face masks, and patient care products. The company is headquartered in Roswell, GA | Health Technology |
FlowCardia, Inc.
FlowCardia, Inc. Medical SpecialtiesHealth Technology FlowCardia, Inc. designs, develops and manufactures endovascular devices. It offers flowmate Injector to optimize the performance of crosser cto recanalization and crosser catheter, a minimally-invasive endovascular device. The firm also provides portfolio of catheter-based technologies to facilitate guidewire crossing of totally occluded coronary and peripheral arteries. The company was founded by Henry Nita and Erik T. Engelson in 2001 and is headquartered in Sunnyvale, CA. | Health Technology |
Covidien Unlimited Co.
Covidien Unlimited Co. Medical SpecialtiesHealth Technology Covidien Unlimited Co. engages in the development, manufacture, and sale of healthcare products for use in clinical and home settings. It operates through Medical Devices and U.S. Medical Supplies segments. The Medical Devices segment involves in the distribution of surgical solutions, peripheral vascular and neurovascular therapies, patient monitoring products, and airway and ventilation products. The U.S. Medical Supplies segment includes marketing of nursing care, medical surgical, SharpSafety brand, and original equipment manufacturer (OEM) products. The company was founded in 1967 and is headquartered in Dublin, Ireland. | Health Technology |
Sonablate Corp.
 Sonablate Corp. Medical SpecialtiesHealth Technology Sonablate Corp. develops and manufactures high intensity focused ultrasound surgical ablation systems. Its products include Sonablate 450, a HIFU solution that determines the safety and efficacy of a minimally invasive prostate cancer treatment; Sonablate 500, a HIFU surgical ablation system for the treatment of localized prostate cancer that delivers ablative therapy with the possibility of reducing side effects; and Sonatherm, a laparoscopic HIFU surgical ablation system that uses a laparoscopic probe to deliver robotic ablative therapy to soft tissue with a customizable ablation zone. The company was founded by Stephen R. Puckett Sr. and George M. Suarez in 2004 and is headquartered in Charlotte, NC. | Health Technology |
On Target Laboratories LLC
On Target Laboratories LLC BiotechnologyHealth Technology On Target Laboratories LLC develops precise and innovative small molecules whose goal is to target and illuminate cancer and other diseased tissue. The company is headquartered in Northbrook, IL. | Health Technology |
Radiaction Ltd.
Radiaction Ltd. Electronic Equipment/InstrumentsElectronic Technology Radiaction Ltd.engages in the development of an innovative radiation shielding system. Its technology offers full body protection, automatic operation, zero-impact on image quality, and lead-free and non-toxic materials. The company was founded by Amir Belson in 2014 and is headquartered in Tel Aviv, Israel. | Electronic Technology |
- Stock Market
- Insiders
- Christopher Barys
